Seeking Alpha

CEPH Transcripts Search Results

Results 1-10 for fentora (out of 14)
Refine your search:

You can use: AND, NOT, OR, " " (exact phrase)

Search across all Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)


  • Cephalon Q3 2009 Earnings Call Transcript 27 Oct, 2009
    ... continue to grow and believe our FENTORA REMS will ensure appropriate patient safety ... pave their way for broader FENTORA label. In addition, we will ... with Teva or potentially with FENTORA label expansion just trying to ...
  • Cephalon, Inc. Q2 2009 Earnings Call Transcript 04 Aug, 2009
    ... property stake surrounding this product. FENTORA continues to contribute to our ... to obtain approval for broader FENTORA label. On the mergers and ... market expansion. We're expecting FENTORA to maintain a dominant share ...
  • Cephalon Inc. Q1 2009 Earnings Call Transcript 05 May, 2009
    ... significant growth driver for the company. FENTORA continues to be steady sales ... additional indications. We submitted our FENTORA REMS to the FDA, which ... forward our sNDA for broader FENTORA label. Over the last several ...
  • Cephalon, Inc., Q4 2008 Earnings Call Transcript 13 Feb, 2009
    ... We received European Commission approval for Fentora and are now beginning to ... broader label, we believe that FENTORA will present a tremendous benefit ... and TREANDA, NUVIGIL et cetera, Fentora hopefully by that point of ...
  • Cephalon Inc. Q3 2008 Earnings Conference Call Transcript 28 Oct, 2008
    ... anticipation of switching manufacturing to FENTORA to prepare for its launch. ... fully up and running for FENTORA? Frank Baldino, Jr., Ph.D. - ... Jefferies & Company Right, for FENTORA? Unidentified Company Representative That's ...
  • Cephalon, Inc. Q2 2008 Earnings Call 30 Jul, 2008
    ... ensure safe and effective use of FENTORA and the patient populations indicated for ... concerns for a product like FENTORA were use in opiod non-tolerant ... some one could address the FENTORA patent challenges that you have ...
  • Cephalon, Inc. Q1 2008 Earnings Call Transcript 02 May, 2008
    ... European regulatory authorities approved the FENTORA for the management of breakthrough ... interactions with FDA on the FENTORA issue whatsoever and merely reflecting ... moved up on ACTIQ and FENTORA during the quarter. Was that ...
  • Cephalon, Inc. Q4 2007 Earnings Call Transcript 12 Feb, 2008
    ... Last month we announced that FENTORA has been recommended for approval in ... sales were $512.6 million, with FENTORA sales were $135.1 million. This ... launching TREANDA and do promote FENTORA into their target audiences as ...
  • Cephalon Q3 2007 Earnings Call Transcript 08 Nov, 2007
    ... We successfully completed our study with FENTORA, in opioid-tolerant patients with non-cancer breakthrough pain ... demonstrate the broad clinical utility of FENTORA, in opioid-tolerant patients suffering from breakthrough ...
  • Cephalon Q2 2007 Earnings Call Transcript 31 Jul, 2007
    ... cancer pain. We conducted clinical studies of FENTORA that demonstrated statistically significant pain relief ... pain. Clearly expanding label indications of FENTORA to opioid-tolerant patients beyond breakthrough cancer ...
Search CEPH Transcripts:

You can use: AND, NOT, OR, " " (exact phrase)

Most Popular Searches

in CEPH transcripts

Other Transcripts
from the Biotech Sector
  1. Arrowhead Research Corp. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
  2. Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
  3. Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
To search across transcripts, find the most recent and most popular and view by sector, try: Seeking Alpha's Transcript Center